Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04334668
NA

Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure

Sponsor: The Cleveland Clinic

View on ClinicalTrials.gov

Summary

The investigators are proposing a prospective, randomized, double blinded, placebo-controlled single center study evaluating the role of co-administration of oral sodium chloride (NaCl) with intravenous diuretics in patients hospitalized with acute decompensated heart failure. The investigators are approaching this study with the hypothesis that the use of oral sodium chloride leads to improved effective diuresis (as measured by weight loss) and renal function as compared to placebo in patients hospitalized with acute decompensated heart failure undergoing aggressive intravenous diuretic therapy.

Official title: Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure (OSPREY-AHF)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

67

Start Date

2020-05-20

Completion Date

2026-12-31

Last Updated

2026-02-20

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

Oral Sodium Chloride

Subjects will be randomized to receive 2 grams oral Sodium Chloride three times daily with meals for approximately 4 days

OTHER

Placebo

Subjects will be randomized to receive a placebo three times daily with meals for approximately 4 days.

Locations (1)

Cleveland Clinic

Cleveland, Ohio, United States